CERo Therapeutics Holdings, Inc. (CERO) annual balance sheet — 5-year assets, liabilities & equity history
| Total Current Assets | 1.57M | 2.73M | 3.71M | 1.97M | 42.37M | 1.36M |
| Cash & Short-Term Investments | 857.49K | 1.66M | 3.33M | 1.6M | 42.14M | 1.1M |
| Cash Only | 857.49K | 1.66M | 3.33M | 1.6M | 42.14M | 1.1M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - |
| Other Current Assets | 716.91K | 1.07M | 386.98K | 341.35K | 225.19K | 262.5K |
| Total Non-Current Assets | 630.71K | 906.85K | 2.49M | 3.16M | 4.27M | 178.72M |
| Property, Plant & Equipment | 630.71K | 906.85K | 1.99M | 3.16M | 4.27M | 4.65M |
| Fixed Asset Turnover | 0.00x | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 1.3M | 0 | 0 | 178.5M |
| Other Non-Current Assets | 0 | 0 | -795.44K | 0 | 0 | 200.65K |
| Total Assets | 2.21M | 3.64M | 6.21M | 5.13M | 42.37M | 180.08M |
| Asset Turnover | 0.00x | - | - | - | - | - |
| Asset Growth % | -169.35% | -41.34% | 21.08% | -87.9% | -76.47% | - |
| Total Current Liabilities | 11.33M | 9.09M | 7.4M | 5.17M | 30.75M | 98.07K |
| Accounts Payable | 7.69M | 7.58M | 4.51M | 3.54M | 1.65M | 14.43K |
| Days Payables Outstanding | 2.38K | 2.55K | 1.41K | 1.15K | - | - |
| Short-Term Debt | 0 | 0 | 876.39K | 1.55M | 650K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 597.5K | 0 |
| Other Current Liabilities | 3.18M | 722.09K | 264.3K | 23.63K | 27.77M | -585.25K |
| Current Ratio | 0.14x | 0.30x | 0.50x | 0.38x | 1.38x | 13.88x |
| Quick Ratio | 0.14x | 0.30x | 0.50x | 0.38x | 1.38x | 13.88x |
| Cash Conversion Cycle | - | - | - | - | - | - |
| Total Non-Current Liabilities | 136.76K | 0 | 699.11K | 17.59M | 9.15M | 9.15M |
| Long-Term Debt | 136.76K | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 218.31K | 0 | 699.11K | 1.58M | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 17.59M | 9.15M | 9.15M |
| Total Liabilities | 11.46M | 9.09M | 8.1M | 47.18M | 39.9M | 9.25M |
| Total Debt | 598.35K | 699.11K | 1.58M | 1.55M | 650K | 3.6M |
| Net Debt | -259.14K | -963.27K | -1.75M | 1.46M | -41.49M | 2.5M |
| Debt / Equity | -0.06x | - | - | - | 0.26x | 0.02x |
| Debt / EBITDA | -0.03x | - | - | - | 650000.00x | 8.93x |
| Net Debt / EBITDA | 0.01x | - | - | - | -999999.00x | 6.21x |
| Interest Coverage | -114.66x | - | - | - | - | - |
| Total Equity | -9.26M | -5.45M | -1.89M | -5.76M | 2.47M | 170.83M |
| Equity Growth % | -2886.93% | -187.48% | 67.12% | -333.44% | -98.55% | - |
| Book Value per Share | -0.32 | -1.29 | -15.68 | -783.74 | 335.74 | 23232.71 |
| Total Shareholders' Equity | -9.26M | -5.45M | -1.89M | -5.76M | 2.47M | 170.83M |
| Common Stock | 3.6K | 2.11K | 242 | 0 | 13.22M | 178.5M |
| Retained Earnings | -96.72M | -90.84M | -70.92M | -43.09M | -10.76M | -7.67M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying CERO stock.
As of 2025, CERo Therapeutics Holdings, Inc. (CERO) had total assets of $3.6M including $2.7M in current assets.
CERo Therapeutics Holdings, Inc. (CERO) carries total debt of $0.7M, offset by $1.7M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
CERo Therapeutics Holdings, Inc. (CERO) has total shareholders' equity (book value) of $-5.4M ($-1.29 book value per share). Book value represents the net worth of the company belonging to common stock holders.
CERo Therapeutics Holdings, Inc. (CERO) reported a current ratio of 0.30x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.